Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

UFS unveils portrait of Ms Winkie Direko
2005-11-28

During the unveiling ceremony were from the left Prof Frederick Fourie (Rector and Vice-Chancellor of the UFS), Mrs Direko, Judge Faan Hancke (Chairperson of the UFS Council) and Dr Charles Nwaila (Director-General of the Free State Provincial Government and Vice-Chairperson of the UFS Council). The blue background of the portrait depicts Ms Direko's philosophy of "the sky is the limit".  She also wore the same outfit as what she has on in the portrait. Photo:  Stephen Collett

UFS unveils portrait of Ms Winkie Direko  
A portrait of Ms Winkie Direko, former Chancellor of the University of the Free State (UFS) and Premier of the Free State Province and currently a Member of Parliament, was unveiled today during the last session of the UFS Council for this year on the Main Campus in Bloemfontein.

The portrait, painted by the gifted artist Ms Reshada Crouse, now hangs in the Council Chambers of the UFS.

Ms Direko was sworn in as Chancellor of the UFS in August 1999.  She was the first black person and first woman in this position at the UFS. She was succeeded by Dr Franklin Sonn.

“Ms Direko had an exceptional legitimacy in the black community because of her role in black education in the Free State (as principal) and community leader in the difficult ‘struggle’ period.  This former principal’s simultaneous insistence on transformation as well as discipline and order at an educational institution was exactly what the UFS needed at that stage,” said Prof Frederick Fourie, Rector and Vice-Chancellor, during the unveiling ceremony.

“She also played a special role to bring the UFS and the Free State Provincial Government closer to each other.  Her comprehension for the own nature of a university helped in times when difficult decisions had to be made.  She also realised the value of the university’s expertise for her government.  The Premier’s Economic Advisory Council, with the UFS rector and academics like Lucius Botes and James Moses in leading roles, was formed to undertake important research on economic development strategies in the Free State,” said Prof Fourie.

In her speech Ms Direko said that it is an unique experience for her to be catalogued in the history of the UFS.  “I am humbled and proud to be associated with the UFS,” she said.

Ms Direko said that the UFS is on the right track with its transformation process.  “I will continue to convince people that the UFS is for everyone and will fight for that until the end.  But, it is important to see a visible change concerning transformation.  The UFS must bring its side and speed up the transformation process.  I know that it is a difficult road, but we cannot hide from the realities of our time,” she said.
 

Media release
Issued by: Lacea Loader
Media Representative
Tel:  (051) 401-2584
Cell:  083 645 2454
E-mail:  loaderl.stg@mail.uovs.ac.za
25 November 2005

 

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept